Susanne Schaffert - Jul 12, 2022 Form 3 Insider Report for Rubius Therapeutics, Inc. (RUBY)

Role
Director
Signature
/s/ Maiken Keson-Brookes, as Attorney-in-Fact
Stock symbol
RUBY
Transactions as of
Jul 12, 2022
Transactions value $
$0
Form type
3
Date filed
7/19/2022, 05:54 PM
Next filing
Aug 1, 2022

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney